Phase 1 Clinical Trial – Medical Alley Association

Phase 1 Clinical Trial

Nucleus Network Begins Clinical Trial of COVID-19 Antibody Treatment

Melbourne, Australia, Friday, 11th September. Australia’s largest Phase 1 clinical trials specialist, Nucleus Network, has this week started the first human trials of a potential COVID-19 treatment developed by Singlomics (Beijing DanXu) Biopharmaceuticals and licensed by BeiGene, Ltd. Twenty-four healthy participants, aged 18 to 59 years of age, have been screened to take part this […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER